Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer
Dmitri Pchejetski(University of East Anglia), Leonardo Monzon(St Mary's Hospital), Aun Muhammad(Whittington Hospital), Albandri Alfraidi(Imperial College London), Keith Sacco(Phoenix Children's Hospital), Heba Alshaker(University of East Anglia)
Cited by 28
Related Papers
Sphingosine Kinase-1 as a Chemotherapy Sensor in Prostate Adenocarcinoma Cell and Mouse Models
|Cancer Research|2005|203
Oxidative Stress–Dependent Sphingosine Kinase-1 Inhibition Mediates Monoamine Oxidase A–Associated Cardiac Cell Apoptosis
|Circulation Research|2006|197
The emerging role of FTY720 (Fingolimod) in cancer treatment
|Oncotarget|2016|174
Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting shingosine kinase-1
|Leukemia|2005|171
Apelin prevents cardiac fibroblast activation and collagen production through inhibition of sphingosine kinase 1
|European Heart Journal|2011|163